David Breeze, the company’s managing director and executive chairman, said part of the funds will be used for the next-phase development of Cortical Dynamics’ anaesthesia monitoring EEG-based device called BARM, which stands for brain anaesthesia response monitor.
Cortical’s BARM device helps keep the patient optimally anaesthetised during surgery, and Breeze emphasised the significant unmet need in the anaesthetics community to not only optimally anaesthetise the patient, but also administer the appropriate dose of analgesia.
“Cortical already is registered in the US Food and Drug Administration, in Korea, in Europe and in Australia. It is currently going through the next phase of development. In other words, a model two enhancement of all the components — software, hardware, firmware,” Breeze said. “We’ll be looking in terms of the value inflection point to have those elements of technical advancement registered and accepted by the regulatory authorities as upgrades for that technology.”
Watch the full interview with BPH Energy Managing Director and Executive Chairman David Breeze above.
INN does not provide investment advice and the information on this profile should not be considered a recommendation to buy or sell any security. INN does not endorse or recommend the business, products, services or securities of any company profiled.
This interview may contain forward-looking statements including but not limited to comments regarding the timing and content of upcoming work programs, receipt of property titles, etc. Forward-looking statements address future events and conditions and therefore involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements. The issuer relies upon litigation protection for forward-looking statements. Investing in companies comes with uncertainties as market values can fluctuate.
Leave a Reply